In comparison, the lower adherence to treatment in the second period in our institution reflects an increasing trend to seek anti-VEGF treatment and follow-up by the patients’ family ophthalmologists, rather than a treatment interruption (Table 1 ) [ 26 ].
← all excerpts
Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland.
1
—
—